#Healthcare

Pharma Physical Supply Chain Software

The pharma supply chain is becoming more complex as specialty therapeutics, biologics, cell and gene therapies and personalized medicine continue to grow. Cloud-based workflows, governed data and workflow-specific AI are beginning to connect manufacturing, quality, logistics and distribution, helping operators understand what is happening, what is at risk and what to do next.

LLR has spent over two decades investing in healthcare technology businesses and is watching the space closely. Companies and intermediaries working in this space should contact Will Sadock to discuss relevant investment opportunities.

The next generation of vendors is not just digitizing the status quo. It is moving from static records and disconnected portals to orchestrated execution from initial design all the way through to dispense.

Anshul Mangal, LLR Advisor & President, PerkinElmer OneSource

Tailwinds Accelerating Demand for Pharma Physical Supply Chain Software

Specialized Therapy Complexity: As specialty therapeutics take greater share, the physical pharma supply chain is becoming harder to operate and more complex, as it requires precise handling across production, packaging, storage, distribution and dispense.

Expanding Compliance Burdens: Traceability requirements are raising expectations for documentation, serialization, auditability and real-time visibility throughout manufacturing and distribution.

Global Networks Require Coordination: Pharmaceutical companies must coordinate sourcing, quality, logistics and distribution across increasingly global networks of suppliers, manufacturers and distribution partners.

 

The value proposition for pharma physical supply chain software

55%
1
of innovative drug sales are represented by biologics
28%
2
of API facilities supplying the U.S. market are located domestically

Key Focus Areas for LLR Investment

Our areas of focus span software that helps pharmaceutical companies coordinate regulated operations across manufacturing, quality, logistics and distribution:

Manufacturing Execution & Laboratory Operations, including platforms supporting manufacturing execution systems (MES), laboratory information management systems (LIMS), electronic batch records and production analytics that improve manufacturing visibility and operational efficiency.

Quality, Compliance & Validation, including solutions supporting quality management, digital validation, audit readiness, documentation and regulatory compliance throughout pharmaceutical manufacturing.

Supply Chain Visibility & Cold Chain, including platforms that improve serialization, chain of custody, cold-chain monitoring, track-and-trace and logistics coordination across manufacturing partners and distribution networks.

AI Orchestration & Connected Operations, including software that connects manufacturing, quality, logistics and supply chain workflows into a unified operating layer, helping operators understand what is happening, identify risks and coordinate decisions across regulated environments.

Our Strategic Network

Portfolio companies gain access to LLR’s in-house Value Creation and Market Development resources, along with our extensive network of industry relationships, built over 25 years of investing in healthcare businesses.

Select Investment Experience

LLR invests in the sectors where our investment experience indicates there are attractive business models and market trends supporting strong growth potential. Here are some of our related investments.

Latest GrowthBits

View All
#Healthcare
From Design to Dispense: Pharma’s Supply Chain Enters the AI Orchestration Era
William Sadock / Vice President

Meet the LLR Team

Zack Sigal

Zack Sigal
William Sadock

William Sadock
Tyler Wincig

Tyler Wincig
Dylan Kim

Dylan Kim
Ankush Somenhalli

Ankush Somenhalli
Charles Qu

Charles Qu

Related News

News

September 8, 2022

LLR Partners Announces Significant Growth Investment in VPL

LLR Partners today announced a significant growth investment in Vantage Point Logistics (“VPL”), a supply chain management software provider that helps...

References

  1. “The Rise of Biologics: Emerging Trends and Opportunities,” CAS, 2024, https://www.rbccm.com/en/gib/healthcare/episode/the_healthcare_data_explosion
  2. “Building a Resilient and Secure Pharmaceutical Supply Chain,” Duke-Margolis Institute for Health Policy, 2024, https://healthpolicy.duke.edu/sites/default/files/2024-11/Building%20a%20Resilient%20and%20Secure%20Pharmaceutical%20Supply%20Chain.pdf
Disclaimer:

The information presented herein is intended for an audience of potential LLR portfolio companies and the intermediaries supporting their capital raise processes. Named LLR investments presented herein do not reflect a complete list of LLR investments and are provided for informational purposes only. Certain statements about LLR made by portfolio company executives and other quoted parties herein are intended to illustrate the work of LLR and its Value Creation Team with such portfolio companies or reflect the individual’s perspective on the featured industry sector. Such portfolio companies are controlled by investment vehicles managed by LLR. Quoted parties were not compensated in connection with their participation, although they generally receive compensation and investment opportunities in connection with their portfolio company or as a Senior Operating Advisor or engaged consultants paid by LLR and in certain cases are also owners of portfolio company securities and/or investors in LLR-sponsored vehicles. Such compensation and investments subject participants to potential conflicts of interest in making statements herein.